On Tuesday, Pulmonx Corp (NASDAQ: LUNG) opened higher 1.47% from the last session, before settling in for the closing price of $7.50. Price fluctuations for LUNG have ranged from $7.11 to $14.84 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 30.02% over the past five years. Company’s average yearly earnings per share was noted -15.97% at the time writing. With a float of $34.95 million, this company’s outstanding shares have now reached $38.52 million.
Let’s look at the performance matrix of the company that is accounted for 279 employees.
Pulmonx Corp (LUNG) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Pulmonx Corp is 9.31%, while institutional ownership is 87.82%. The most recent insider transaction that took place on Apr 22 ’24, was worth 8,868. In this transaction CHIEF COMMERCIAL OFFICER of this company sold 1,184 shares at a rate of $7.49, taking the stock ownership to the 306,684 shares. Before that another transaction happened on Mar 22 ’24, when Company’s CHIEF COMMERCIAL OFFICER sold 1,184 for $9.36, making the entire transaction worth $11,082. This insider now owns 307,868 shares in total.
Pulmonx Corp (LUNG) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -15.97% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 23.60% during the next five years compared to -25.16% drop over the previous five years of trading.
Pulmonx Corp (NASDAQ: LUNG) Trading Performance Indicators
Check out the current performance indicators for Pulmonx Corp (LUNG). In the past quarter, the stock posted a quick ratio of 5.77. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.27.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.60, a number that is poised to hit -0.47 in the next quarter and is forecasted to reach -1.58 in one year’s time.
Technical Analysis of Pulmonx Corp (LUNG)
Pulmonx Corp (NASDAQ: LUNG) saw its 5-day average volume 0.44 million, a negative change from its year-to-date volume of 0.5 million. As of the previous 9 days, the stock’s Stochastic %D was 54.36%. Additionally, its Average True Range was 0.36.
During the past 100 days, Pulmonx Corp’s (LUNG) raw stochastic average was set at 6.47%, which indicates a significant decrease from 38.76% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 38.15% in the past 14 days, which was lower than the 56.28% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.89, while its 200-day Moving Average is $10.78. Nevertheless, the first resistance level for the watch stands at $7.75 in the near term. At $7.89, the stock is likely to face the second major resistance level. The third major resistance level sits at $8.12. If the price goes on to break the first support level at $7.38, it is likely to go to the next support level at $7.15. The third support level lies at $7.01 if the price breaches the second support level.
Pulmonx Corp (NASDAQ: LUNG) Key Stats
There are currently 38,537K shares outstanding in the company with a market cap of 293.29 million. Presently, the company’s annual sales total 68,680 K according to its annual income of -60,840 K. Last quarter, the company’s sales amounted to 19,280 K and its income totaled -13,890 K.
